Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries has said that it will continue to sell its generic version of the painkiller OxyContin tablets at least through the end of 2007.
Subscribe to our email newsletter
In October 2006, Teva settled a patent dispute with the Purdue Frederick Company and certain of its affiliates pertaining to Teva's generic version of Purdue's OxyContin tablets.
The settlement provided a full release of Teva and its distributors, purchasers and patients and requires Teva to cease sales of the product upon the occurrence of certain contingencies.
Oxycontin tablets are controlled-release drugs that are prescribed for moderate to severe pain when relief is needed for an extended period of time.